Brief: Pulse Biosciences Announces Collaboration With Cardionxt For NSPFA First-In-Human Atrial Fibrillation Study
02/10/2023 14:36
Oct 2 (Reuters) - Pulse Biosciences Inc PLSE.O :
* PULSE BIOSCIENCES ANNOUNCES COLLABORATION WITH CARDIONXT
FOR
NSPFA FIRST-IN-HUMAN ATRIAL FIBRILLATION STUDY
Source text for Eikon: ID:nBw5MRSJca
Further company coverage: PLSE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pulse Biosciences
See all newsBrief: Pulse Biosciences, Inc. Announces Planned Redemption Of Warrants
Chairmen Total Approximately $13.3 Million
Pulse Biosciences records Q1 revenue, but loss widens on higher clinical investment
Brief: Pulse Biosciences Q1 Net Income USD -18.581 Million
Brief: Pulse Biosciences Announces Positive Clinical Data From Npulse Cardiac Catheter System